Calidi Biotherapeutics Inc (CLDI)
0.2304
-0.01
(-4.79%)
USD |
NYAM |
May 17, 16:00
0.2304
0.00 (0.00%)
Pre-Market: 20:00
Calidi Biotherapeutics Total Assets (Quarterly): 10.02M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.02M |
September 30, 2023 | 18.59M |
June 30, 2023 | 10.18M |
Date | Value |
---|---|
December 31, 2022 | 2.597M |
September 30, 2022 | 1.618M |
December 31, 2021 | 3.391M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.618M
Minimum
Sep 2022
18.59M
Maximum
Sep 2023
7.732M
Average
6.705M
Median
Total Assets (Quarterly) Benchmarks
Minerva Neurosciences Inc | 50.51M |
Viking Therapeutics Inc | 967.52M |
CytomX Therapeutics Inc | 184.69M |
Genprex Inc | 10.67M |
Janux Therapeutics Inc | 688.98M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 18.25M |
Shareholders Equity (Quarterly) | -8.235M |